The Administrative Core (Core A) will serve as the administrative and operational hub of the Duke CFAR, providing oversight for all CFAR-related activities. Most importantly. Core A will work with the Department of Surgery, the academic home of the Duke CFAR, to provide overall financial management for the entire CFAR, and thereby maximize the impact of available CFAR funding on the establishment of critical infrastructure and an array of different support mechanisms in service to the community of HIV/AIDS researchers at Duke. This will include budget management of all CFAR Cores, matching fund allocation through the School of Medicine, and any other resources made available to the CFAR. The Core will work closely with the External and Internal Advisory Committees as well as the CFAR Executive Committee to fully implement all approved directives, programmatic changes and new initiatives, thus facilitating all aspects of the CFAR Strategic Planning process. Core A will organize all symposia, scientific retreats, yearly reviews, CFAR seminars, and strategic planning sessions, and will assist the Basic Science Director and the Developmental Core Director in conducting scientific peer review of the applications received in response to semi-annual Duke CFAR RFAs. The Administrative Core will promote comprehensive communication among the CFAR membership through the Duke CFAR website (www.cfar.duke.edu). an e-mail listserve, and a quarterly newsletter, and will establish additional open lines of communication as the need arises. Finally, the Core will serve as the main point of contact between the Duke CFAR and NIH Program Staff, and the Core will be responsible for organizing and submitting all forms of written communication with the NIH, including annual Progress Reports, requests for supplemental funding, requests for investigator status changes, rebudgeting requests, and competitive renewal applications.

Public Health Relevance

The Duke CFAR will create critical infrastructure and provides a variety of important support mechanisms to basic and clinical investigators conducting HIV/AIDS research at Duke. Facilitation of these broad and highly intensive research efforts will accelerate the discovery of important new therapeutic modalities and vaccine strategies that will serve as future tools for treatment and prevention of HIV-1 infection and thedevastafing effects of AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI064518-08
Application #
8379347
Study Section
Special Emphasis Panel (ZAI1-JBS-A)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
8
Fiscal Year
2012
Total Cost
$180,598
Indirect Cost
$82,041
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Ramadhani, Habib O; Muiruri, Charles; Maro, Venance P et al. (2017) Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance. AIDS Behav :
Han, Qifeng; Williams, Wilton B; Saunders, Kevin O et al. (2017) HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques. J Virol 91:
Margolis, David M; Koup, Richard A; Ferrari, Guido (2017) HIV antibodies for treatment of HIV infection. Immunol Rev 275:313-323
Pollara, Justin; Easterhoff, David; Fouda, Genevieve G (2017) Lessons learned from human HIV vaccine trials. Curr Opin HIV AIDS 12:216-221
Wang, Kening; Tomaras, Georgia D; Jegaskanda, Sinthujan et al. (2017) Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice J Virol 91:
Price, Alexander M; Dai, Joanne; Bazot, Quentin et al. (2017) Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection. Elife 6:
Martinez, David R; Vandergrift, Nathan; Douglas, Ayooluwa O et al. (2017) Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk. J Virol 91:
Marks, Florian; von Kalckreuth, Vera; Aaby, Peter et al. (2017) Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study. Lancet Glob Health 5:e310-e323
Towe, Sheri L; Patel, Puja; Meade, Christina S (2017) The Acceptability and Potential Utility of Cognitive Training to Improve Working Memory in Persons Living With HIV: A Preliminary Randomized Trial. J Assoc Nurses AIDS Care 28:633-643
Kelly, Matthew S; Surette, Michael G; Smieja, Marek et al. (2017) The Nasopharyngeal Microbiota of Children With Respiratory Infections in Botswana. Pediatr Infect Dis J 36:e211-e218

Showing the most recent 10 out of 468 publications